课题基金 / 基金详情

HIGHLY ATTENUATED SIV VIF DNA VACCINES

HIGHLY ATTENUATED SIV VIF DNA VACCINES
高度减毒 SIV VIF DNA 疫苗
批准号:
7959001
负责人:
Ellen Elizabeth Sparger
金额:
$14.66万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30

项目摘要

项目成果

Ellen Elizabeth Sparger的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The accessory gene vif of lentiviruses is required for efficient viral replication. Vif inhibits virion incorporation of a cellular cytidine deaminase, APOBEC3G, by targeting this cellular protein for proteosomal degradation. A vif-deleted virus may be persistent in the host, although at extremely low levels and restricted to specific tissues or cell subsets with reduced expression of APOBEC3 proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GMP production and GLP safety of bidirectionally targeted SARS-CoV-2 booster vaccine
  • 批准号:
    10766657
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2023
  • 负责人:
    Ellen Elizabeth Sparger
  • 依托单位:
HIGHLY ATTENUATED SIV VIF DNA VACCINES
  • 批准号:
    7715581
  • 项目类别:
  • 资助金额:
    $16.9万
  • 财政年份:
    2008
  • 负责人:
    Ellen Elizabeth Sparger
  • 依托单位:
Cellular Immune Responses Induced by SIVdelta-vif plus IL-15 DNA Vaccine
  • 批准号:
    7494904
  • 项目类别:
  • 资助金额:
    $7.6万
  • 财政年份:
    2008
  • 负责人:
    Ellen Elizabeth Sparger
  • 依托单位:
HIGHLY ATTENUATED SIV VIF DNA VACCINES
  • 批准号:
    7562168
  • 项目类别:
  • 资助金额:
    $18.16万
  • 财政年份:
    2007
  • 负责人:
    Ellen Elizabeth Sparger
  • 依托单位:
海外基金